Acro Biomedical (ACBM) Cash & Equivalents (2015 - 2026)
Acro Biomedical (ACBM) posted Cash & Equivalents of $3648.0 for Q2 2026, down 10.98% on a QoQ basis from $4098.0 in Q4 2025, and up 13930.77% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Cash & Equivalents (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Cash & Equivalents for 12 years, with the latest figure at $3648.0 in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 13930.77% year-over-year to $3648.0 in Q2 2026; TTM through Jun 2026 was $3648.0, a 13930.77% increase from a year earlier, with the FY2025 full-year figure at $4098.0, up 760.92% from the prior year.
- Cash & Equivalents was $3648.0 for Q2 2026 at Acro Biomedical, down from $4098.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $357668.0 in Q1 2022, with the low at $26.0 in Q2 2025.
- Average Cash & Equivalents over 5 years is $24297.9, with a median of $2680.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash & Equivalents slumped 99.91% in 2023, then surged 13930.77% in 2026.
- Over 5 years, Cash & Equivalents stood at $5852.0 in 2022, then plunged by 93.57% to $376.0 in 2023, then rose by 26.6% to $476.0 in 2024, then soared by 760.92% to $4098.0 in 2025, then slipped by 10.98% to $3648.0 in 2026.
- The last three Cash & Equivalents figures came in at $3648.0 (Q2 2026), $4098.0 (Q4 2025), and $4323.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.37 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 1.11 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 956.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 794.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 63.87 Mn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 399.70 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 370.50 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 397.10 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 3,199.00 |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 3,648.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,648.00 |
| Dec 31, 2025 | 4,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 26.00 |
| Mar 31, 2025 | 251.00 |
| Dec 31, 2024 | 476.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 151.00 |
| Dec 31, 2023 | 376.00 |
| Sep 30, 2023 | 3,271.00 |
| Jun 30, 2023 | 2,680.00 |
| Mar 31, 2023 | 322.00 |
| Dec 31, 2022 | 5,852.00 |
| Sep 30, 2022 | 16,188.00 |
| Jun 30, 2022 | 12,107.00 |
| Mar 31, 2022 | 357,668.00 |
| Dec 31, 2021 | 95,248.00 |
| Sep 30, 2021 | 154,663.00 |
| Jun 30, 2021 | 215,494.00 |